Aurora Cannabis (ACB) Change in Working Capital (2018 - 2026)

Aurora Cannabis (ACB) posted quarterly Change in Working Capital of $330.5 million for Q1 2026, down 10.05% year-on-year from $367.5 million in Q1 2025, and up 10.21% on a QoQ basis from $299.9 million in Q4 2025.

Aurora Cannabis (ACB) Change in Working Capital (2018 - 2026) Analysis & Trends

Aurora Cannabis (ACB) has reported Change in Working Capital for 9 consecutive years, with $330.5 million the latest figure, recorded in Q1 2026.

  • Quarterly Change in Working Capital fell 10.05% year-over-year to $330.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 172.42% YoY) and the FY2026 annual result came in at $6.7 million, down 53.06% from the prior year.
  • Change in Working Capital improved to $330.5 million in Q1 2026 per ACB's latest filing, from $299.9 million in the prior quarter.
  • Over the last five years, Change in Working Capital for ACB reached as high as $367.5 million in Q1 2025 and fell as low as -$21.7 million in Q3 2024.
  • A 5-year average of $80.4 million and a median of $15.4 million in 2024 frame the typical range for Change in Working Capital.
  • Annual changes were most pronounced in 2022 — Change in Working Capital plunged 197.5% — and 2025, when it soared 2286.66%.
  • Year by year, Change in Working Capital stood at -$18.7 million in 2022, then surged by 129.73% to $5.6 million in 2023, then soared by 261.8% to $20.1 million in 2024, then jumped by 1391.53% to $299.9 million in 2025, then rose by 10.21% to $330.5 million in 2026.
  • According to Business Quant data, Change in Working Capital over the past three periods registered $330.5 million, $299.9 million, and $367.5 million for Q1 2026, Q4 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -617.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn 330.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 330.52 Mn
Mar 31, 2026 330.52 Mn
Dec 31, 2025 299.90 Mn
Dec 31, 2025 299.90 Mn
Mar 31, 2025 367.47 Mn
Mar 31, 2025 367.47 Mn
Dec 31, 2024 20.11 Mn
Dec 31, 2024 20.11 Mn
Sep 30, 2024 -21.69 Mn
Sep 30, 2024 -21.69 Mn
Jun 30, 2024 7.81 Mn
Jun 30, 2024 7.81 Mn
Mar 31, 2024 15.40 Mn
Mar 31, 2024 15.40 Mn
Dec 31, 2023 5.56 Mn
Dec 31, 2023 5.56 Mn
Sep 30, 2023 -11.03 Mn
Sep 30, 2023 -11.03 Mn
Dec 31, 2022 -18.69 Mn
Dec 31, 2022 -18.69 Mn